"Eur J Pharm Sci"[ Journal] - Search Results

Year	Number of Results
1998	50
1999	104
2000	119
2001	127
2002	115
2003	131
2004	164
2005	191
2006	189
2007	145
2008	192
2009	227
2010	224
2011	258
2012	317
2013	347
2014	309
2015	343
2016	483
2017	645
2018	580
2019	446
2020	469
2021	427
2022	287
2023	320
2024	142

1

Current uncertainties and challenges of publicly available pharmaceutical environmental risk assessment data.

Ahkola H, Äystö L, Sikanen T, Riikonen S, Pihlaja T, Kauppi S. Ahkola H, et al. Eur J Pharm Sci. 2024 Apr 16;197:106769. doi: 10.1016/j.ejps.2024.106769. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38631463

2

Bifunctional HDAC and DNMT inhibitor induces viral mimicry activates the innate immune response in triple-negative breast cancer.

Fan W, Li W, Li L, Qin M, Mao C, Yuan Z, Wang P, Chu B, Jiang Y. Fan W, et al. Eur J Pharm Sci. 2024 Apr 15:106767. doi: 10.1016/j.ejps.2024.106767. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38636781

3

Curcumin and quercetin co-encapsulated in nanoemulsions for nasal administration: a promising therapeutic and prophylactic treatment for viral respiratory infections.

Vaiss DP, Rodrigues JL, Yurgel VC, do Carmo Guedes F Jr, da Matta LLM, Barros PAB, Vaz GR, Dos Santos RN, Matte BF, Kupski L, Garda-Buffon J, Bidone J, Muccillo-Baisch AL, Sonvico F, Dora CL. Vaiss DP, et al. Eur J Pharm Sci. 2024 Apr 12:106766. doi: 10.1016/j.ejps.2024.106766. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38615970 Free article.

4

Cubic liquid crystals containing propolis flavonoids as in situ thermo-sensitive hydrogel depots for periodontitis treatment: Preparation, pharmacodynamics and therapeutic mechanisms.

Tang M, Li J, Wang G, Wang Y, Peng C, Chang X, Tao Y, Guo J, Gui S. Tang M, et al. Eur J Pharm Sci. 2024 Apr 11;196:106762. doi: 10.1016/j.ejps.2024.106762. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38614153 Free article.

5

Absorption of Cinnarizine from Type II Lipid-Based Formulations: Impact of Lipid Chain Length, Supersaturation, Digestion, and Precipitation Inhibition.

Paulus F, Holm R, Stappaerts J, Bauer-Brandl A. Paulus F, et al. Eur J Pharm Sci. 2024 Apr 10:106765. doi: 10.1016/j.ejps.2024.106765. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38608735 Free article.

6

First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of PA9159 Nasal Spray, a Highly Potent Glucocorticoid in Healthy Chinese Volunteers.

Guo S, Hu Y, Wang C, Zhang Y, Wu F, Ni S, Dai Y, Han Y, Hu M, Lu C, Xi Z, Lu L, Zhao X, Zhang L. Guo S, et al. Eur J Pharm Sci. 2024 Apr 8:106764. doi: 10.1016/j.ejps.2024.106764. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38599506 Free article.

7

Model informed drug development: HSK21542 PBPK model supporting dose decisions in specific populations.

Zhang M, Lei Z, Yao X, Zhang L, Yan P, Wu N, Chen M, Zhang F, Liu D. Zhang M, et al. Eur J Pharm Sci. 2024 Apr 8;196:106763. doi: 10.1016/j.ejps.2024.106763. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38599505 Free article.

8

Unveiling the potential of biomaterials and their synergistic fusion in tissue engineering.

Sanchez Armengol E, Hock N, Saribal S, To D, Summonte S, Veider F, Kali G, Bernkop-Schnürch A, Laffleur F. Sanchez Armengol E, et al. Eur J Pharm Sci. 2024 Apr 3;196:106761. doi: 10.1016/j.ejps.2024.106761. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38580169 Free article. Review.

9

Ex vivo gut-hepato-biliary organ perfusion model to characterize oral absorption, gut-wall metabolism, pre-systemic hepatic metabolism and biliary excretion; application to midazolam.

Stevens LJ, van de Steeg E, Doppenberg JB, Alwayn IPJ, Knibbe CAJ, Dubbeld J. Stevens LJ, et al. Eur J Pharm Sci. 2024 Apr 2;196:106760. doi: 10.1016/j.ejps.2024.106760. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38574899 Free article.

10

Vitamin D loaded into lipid nanoparticles shows insulinotropic effect in INS-1E cells.

Cristelo C, Sá AF, Lúcio M, Sarmento B, Gama FM. Cristelo C, et al. Eur J Pharm Sci. 2024 Apr 2;196:106758. doi: 10.1016/j.ejps.2024.106758. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38570054 Free article.

11

Xuebijing injection and its bioactive components alleviate nephrotic syndrome by inhibiting podocyte inflammatory injury.

Yuan S, Cao Y, Jiang J, Chen J, Huang X, Li X, Zhou J, Zhou Y, Zhou J. Yuan S, et al. Eur J Pharm Sci. 2024 Apr 1;196:106759. doi: 10.1016/j.ejps.2024.106759. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38570053 Free article.

12

Corrigendum to "Enhancement of the solubility and oral bioavailability of altrenogest through complexation with hydroxypropyl-β-cyclodextrin": [European Journal of Pharmaceutical Sciences194 (2024) 106691].

Chen W, Zheng X, Lao W, Wang H, Chen S, Liu C, Chen Z, Bai Y, Zhang H, Zhan X, Wang B. Chen W, et al. Eur J Pharm Sci. 2024 Apr 1;195:106728. doi: 10.1016/j.ejps.2024.106728. Epub 2024 Feb 24. Eur J Pharm Sci. 2024. PMID: 38403507 Free article. No abstract available.

13

Solubility of digitoxin in supercritical CO₂: Experimental study and modeling.

Sheikhi-Kouhsar M, Bagheri H, Alsaikhan F, Aldhalmi AK, Ahmed HH. Sheikhi-Kouhsar M, et al. Eur J Pharm Sci. 2024 Apr 1;195:106731. doi: 10.1016/j.ejps.2024.106731. Epub 2024 Feb 20. Eur J Pharm Sci. 2024. PMID: 38387711 Free article.

14

Intrinsic immunogenicity of liposomes for tuberculosis vaccines: Effect of cationic lipid and cholesterol.

Szachniewicz MM, Neustrup MA, van Meijgaarden KE, Jiskoot W, Bouwstra JA, Haks MC, Geluk A, Ottenhoff THM. Szachniewicz MM, et al. Eur J Pharm Sci. 2024 Apr 1;195:106730. doi: 10.1016/j.ejps.2024.106730. Epub 2024 Feb 20. Eur J Pharm Sci. 2024. PMID: 38382622 Free article.

15

A study on the quantity, type, economic value and reasons for pharmaceutical waste returned to pharmacies in Finland.

Louhisalmi M, Lavikainen P, Sandler C, Kallio S, Kanerva R, Martikainen J, Timonen J. Louhisalmi M, et al. Eur J Pharm Sci. 2024 Apr 1;195:106729. doi: 10.1016/j.ejps.2024.106729. Epub 2024 Feb 16. Eur J Pharm Sci. 2024. PMID: 38369170 Free article.

16

Implementing physics-based digital patient twins to tailor the switch of oral morphine to transdermal fentanyl patches based on patient physiology.

Bahrami F, Rossi RM, De Nys K, Joerger M, Radenkovic MC, Defraeye T. Bahrami F, et al. Eur J Pharm Sci. 2024 Apr 1;195:106727. doi: 10.1016/j.ejps.2024.106727. Epub 2024 Feb 13. Eur J Pharm Sci. 2024. PMID: 38360153 Free article.

17

Equivalence assessment of creams with quali-quantitative differences in light of the EMA and FDA regulatory framework.

Volontè P, Musazzi UM, Arnaboldi L, Ortenzi MA, Casiraghi A, Cilurzo F, Minghetti P. Volontè P, et al. Eur J Pharm Sci. 2024 Apr 1;195:106726. doi: 10.1016/j.ejps.2024.106726. Epub 2024 Feb 12. Eur J Pharm Sci. 2024. PMID: 38354986 Free article.

18

iRGD mediated pH-responsive mesoporous silica enhances drug accumulation in tumors.

Wang X, Zhao Y, Yan M, Liang X, Zhao N, Lu T. Wang X, et al. Eur J Pharm Sci. 2024 Apr 1;195:106725. doi: 10.1016/j.ejps.2024.106725. Epub 2024 Feb 10. Eur J Pharm Sci. 2024. PMID: 38346565 Free article.

19

Investigating distributions of inhaled aerosols in the lungs of post-COVID-19 clusters through a unified imaging and modeling approach.

Zhang X, Li F, Rajaraman PK, Comellas AP, Hoffman EA, Lin CL. Zhang X, et al. Eur J Pharm Sci. 2024 Apr 1;195:106724. doi: 10.1016/j.ejps.2024.106724. Epub 2024 Feb 8. Eur J Pharm Sci. 2024. PMID: 38340875 Free PMC article.

20

Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled single- and multiple-dose escalation study in Chinese healthy subjects.

Li K, Dong L, Gao S, Zhang J, Feng Y, Gu L, Yang J, Liu X, Wang Y, Mao Z, Jiang D, Xia Z, Zhang G, Tang J, Ma P, Zhang W. Li K, et al. Eur J Pharm Sci. 2024 Apr 1;195:106723. doi: 10.1016/j.ejps.2024.106723. Epub 2024 Feb 7. Eur J Pharm Sci. 2024. PMID: 38336251 Free article. Clinical Trial.

21

Water-mediated phase transformations of posaconazole: An intricate jungle of crystal forms.

Guidetti M, Hilfiker R, Kuentz M, Bauer-Brandl A, Blatter F. Guidetti M, et al. Eur J Pharm Sci. 2024 Apr 1;195:106722. doi: 10.1016/j.ejps.2024.106722. Epub 2024 Feb 7. Eur J Pharm Sci. 2024. PMID: 38336250 Free article.

22

Effects of H₂S-donor ascorbic acid derivative and ischemia/reperfusion-induced injury in isolated rat hearts.

Tánczos B, Vass V, Szabó E, Lovas M, Kattoub RG, Bereczki I, Borbás A, Herczegh P, Tósaki Á. Tánczos B, et al. Eur J Pharm Sci. 2024 Apr 1;195:106721. doi: 10.1016/j.ejps.2024.106721. Epub 2024 Feb 6. Eur J Pharm Sci. 2024. PMID: 38331005 Free article.

23

The role of partial area under the curve and maximum concentrations in assessing the bioequivalence of long-acting injectable formulation of exenatide_A sensitivity analysis.

Wang HJ, Hsu LF. Wang HJ, et al. Eur J Pharm Sci. 2024 Apr 1;195:106718. doi: 10.1016/j.ejps.2024.106718. Epub 2024 Feb 3. Eur J Pharm Sci. 2024. PMID: 38316168 Free article.

24

Predicting the intrinsic membrane permeability of Caco-2/MDCK cells by the solubility-diffusion model.

Dahley C, Böckmann T, Ebert A, Goss KU. Dahley C, et al. Eur J Pharm Sci. 2024 Apr 1;195:106720. doi: 10.1016/j.ejps.2024.106720. Epub 2024 Feb 2. Eur J Pharm Sci. 2024. PMID: 38311258 Free article.

25

Small molecules modified mesoporous silica nanoparticles orally deliver indomethacin with synergistic effect.

Yin S, Cai L, Li X, Lin K, Shi X, Zhang H, Wang L, Li J. Yin S, et al. Eur J Pharm Sci. 2024 Apr 1;195:106719. doi: 10.1016/j.ejps.2024.106719. Epub 2024 Feb 1. Eur J Pharm Sci. 2024. PMID: 38309442 Free article.

26

A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases.

Mohammed SW, El-Megrab NA, Hasan AA, Gomaa E. Mohammed SW, et al. Eur J Pharm Sci. 2024 Apr 1;195:106714. doi: 10.1016/j.ejps.2024.106714. Epub 2024 Jan 30. Eur J Pharm Sci. 2024. PMID: 38301972 Free article.

27

Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis.

Wang K, Zhu Y, Xu F, Liu L, Liu L, Shi M, Nie J, Reinhart H, Liu J, Gao Y, Pu X. Wang K, et al. Eur J Pharm Sci. 2024 Apr 1;195:106713. doi: 10.1016/j.ejps.2024.106713. Epub 2024 Feb 1. Eur J Pharm Sci. 2024. PMID: 38295963 Free article.

28

Application of nanofiber-based drug delivery systems in improving anxiolytic effect of new 1,2,3-triazolo-1,4-benzodiazepine derivatives.

Botsula I, Sсhavikin J, Heinämäki J, Laidmäe I, Mazur M, Raal A, Koshovyi O, Kireyev I, Chebanov V. Botsula I, et al. Eur J Pharm Sci. 2024 Apr 1;195:106712. doi: 10.1016/j.ejps.2024.106712. Epub 2024 Jan 28. Eur J Pharm Sci. 2024. PMID: 38290611 Free article.

29

Methotrexate-loaded hyaluronan-modified liposomes integrated into dissolving microneedles for the treatment of psoriasis.

Shen S, Zheng X, Dong X, Fang M, Wan A, Zhu T, Yang Q, Xie J, Yan Q. Shen S, et al. Eur J Pharm Sci. 2024 Apr 1;195:106711. doi: 10.1016/j.ejps.2024.106711. Epub 2024 Jan 28. Eur J Pharm Sci. 2024. PMID: 38290610 Free article.

30

Silk fibroin-based dressings with antibacterial and anti-inflammatory properties.

González-Restrepo D, Zuluaga-Vélez A, Orozco LM, Sepúlveda-Arias JC. González-Restrepo D, et al. Eur J Pharm Sci. 2024 Apr 1;195:106710. doi: 10.1016/j.ejps.2024.106710. Epub 2024 Jan 26. Eur J Pharm Sci. 2024. PMID: 38281552 Free article.

31

Modifying peptide/lipid-associated nucleic acids (PLANAs) for CRISPR/Cas9 ribonucleoprotein delivery.

Alhazza A, Mahdipoor P, Hall R, Manda A, Lohan S, Parang K, Aliabadi HM. Alhazza A, et al. Eur J Pharm Sci. 2024 Apr 1;195:106708. doi: 10.1016/j.ejps.2024.106708. Epub 2024 Jan 21. Eur J Pharm Sci. 2024. PMID: 38262570 Free article.

32

Advancements in preclinical human-relevant modeling of pulmonary vasculature on-chip.

Vo Q, Benam KH. Vo Q, et al. Eur J Pharm Sci. 2024 Apr 1;195:106709. doi: 10.1016/j.ejps.2024.106709. Epub 2024 Jan 19. Eur J Pharm Sci. 2024. PMID: 38246431 Free PMC article. Review.

33

Development strategy of novel drug formulations for the delivery of doxycycline in the treatment of wounds of various etiologies.

Saliy O, Popova M, Tarasenko H, Getalo O. Saliy O, et al. Eur J Pharm Sci. 2024 Apr 1;195:106636. doi: 10.1016/j.ejps.2023.106636. Epub 2024 Jan 6. Eur J Pharm Sci. 2024. PMID: 38185273 Free article. Review.

34

Formulation development of pharmaceutical nanoemulgel for transdermal delivery of feboxostat: Physical characterization and in vivo evaluation.

Khan BA, Ahmad N, Alqahtani A, Baloch R, Rehman AU, Khan MK. Khan BA, et al. Eur J Pharm Sci. 2024 Apr 1;195:106665. doi: 10.1016/j.ejps.2023.106665. Epub 2023 Dec 5. Eur J Pharm Sci. 2024. PMID: 38056779 Free article.

35

Specific transport of temozolomide does not override DNA repair-mediated chemoresistance.

Bahrami K, Kärkkäinen J, Bibi S, Huttunen J, Tampio J, Montaser AB, Moody CL, Lehtonen M, Rautio J, Wheelhouse RT, Huttunen KM. Bahrami K, et al. Eur J Pharm Sci. 2024 Apr 1;195:106661. doi: 10.1016/j.ejps.2023.106661. Epub 2023 Dec 3. Eur J Pharm Sci. 2024. PMID: 38052257 Free article.

36

Modeling the complexity of drug-drug interactions: A physiologically-based pharmacokinetic study of Lenvatinib with Schisantherin A/Schisandrin A.

Zheng A, Yang D, Pan C, He Q, Zhu X, Xiang X, Ji P. Zheng A, et al. Eur J Pharm Sci. 2024 Mar 30;196:106757. doi: 10.1016/j.ejps.2024.106757. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38556066 Free article.

37

Medicinal products with pH-dependent solubility-A problem for BA/BE assessment?

Blume H, Weitschies W. Blume H, et al. Eur J Pharm Sci. 2024 Mar 30;196:106756. doi: 10.1016/j.ejps.2024.106756. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38556065 Free article. Review.

38

Lin Y, Long Y, Wang Y, Wang L, Wang M, Xia X, Chen X, Huang Y, Du P, Wu J, Jia Y, Shen J. Lin Y, et al. Eur J Pharm Sci. 2024 Mar 29;196:106755. doi: 10.1016/j.ejps.2024.106755. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38556064 Free article.

39

Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer.

Frimpong E, Bulusu R, Okoro J, Inkoom A, Ndemazie N, Rogers S, Zhu X, Han B, Agyare E. Frimpong E, et al. Eur J Pharm Sci. 2024 Mar 29;196:106754. doi: 10.1016/j.ejps.2024.106754. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38554983 Free article.

40

Are all measures of liver Kp_uu a function of F_H, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?

Benet LZ, Sodhi JK. Benet LZ, et al. Eur J Pharm Sci. 2024 Mar 22;196:106753. doi: 10.1016/j.ejps.2024.106753. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38522769 Free article.

41

The challenge of downstream processing of spray dried amorphous solid dispersions into minitablets designed for the paediatric population - A sustainable product development approach.

Autzen Virtanen A, Myślińska M, Healy AM, Power E, Madi A, Sivén M. Autzen Virtanen A, et al. Eur J Pharm Sci. 2024 Mar 20;196:106752. doi: 10.1016/j.ejps.2024.106752. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38518998 Free article.

42

Enabling a novel solvent method on Albendazole solid dispersion to improve the in vivo bioavailability.

Han MJ, Zou ZZ. Han MJ, et al. Eur J Pharm Sci. 2024 Mar 18;196:106751. doi: 10.1016/j.ejps.2024.106751. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38508502 Free article. Review.

43

Pharmacokinetics, safety, and tolerability of the novel tetrameric gadolinium-based MRI contrast agent gadoquatrane in healthy Chinese and Japanese men: Two randomized dose-escalation studies including concentration-QTc modeling.

He X, Matsuki S, Li K, Sui Y, Matsuno K, Ren M, Sutter G, Hofmann BM. He X, et al. Eur J Pharm Sci. 2024 Mar 16;196:106749. doi: 10.1016/j.ejps.2024.106749. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38499113 Free article.

44

Efficiency of single pharmaceutical surfactants to mimic intestinal biorelevant media solubilization and dissolution of etravirine: Comparison of intrinsic and film dissolution models.

Oktay AN, Polli JE. Oktay AN, et al. Eur J Pharm Sci. 2024 Mar 16;196:106746. doi: 10.1016/j.ejps.2024.106746. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38499112 Free article.

45

Corrigendum to "Does nonlinear blood-brain barrier transport matter for (lower) morphine dosing strategies?" [European Journal of Pharmaceutical Sciences 187 (2023) 106482].

Gülave B, Budda D, Saleh MA, van Hasselt JC, de Lange EC. Gülave B, et al. Eur J Pharm Sci. 2024 Mar 14:106736. doi: 10.1016/j.ejps.2024.106736. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38490876 Free article. No abstract available.

46

Effects of omitting titanium dioxide from the film coating of a pharmaceutical tablet - An industrial case study of attempting to comply with EU regulation 2022/63.

Galata DL, Sinka Lázárné M, Kiss-Kovács D, Fülöp G, Dávid B, Bogáti B, Ficzere M, Péterfi O, Nagy B, Marosi G, Nagy ZK. Galata DL, et al. Eur J Pharm Sci. 2024 Mar 13;196:106750. doi: 10.1016/j.ejps.2024.106750. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38490522 Free article.

47

Application of bootstrap f₂ to dissolution data from biorelevant media and evidence of the conservative nature of bootstrap f₂.

Jamil R, Polli JE. Jamil R, et al. Eur J Pharm Sci. 2024 Mar 11;196:106745. doi: 10.1016/j.ejps.2024.106745. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38471596 Free article.

48

Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs.

Barlang LA, Deimel I, Mohl BP, Blaurock C, Balkema-Buschmann A, Weinbender K, Hess B, Obernolte H, Merkel OM, Popp A. Barlang LA, et al. Eur J Pharm Sci. 2024 Mar 11;196:106744. doi: 10.1016/j.ejps.2024.106744. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38471595 Free article.

49

In vitro and in ovo photodynamic efficacy of nebulized curcumin-loaded tetraether lipid liposomes prepared by DC as stable drug delivery system.

Bender L, Preis E, Engelhardt KH, Amin MU, Ayoub AM, Librizzi D, Roschenko V, Schulze J, Yousefi BH, Schaefer J, Bakowsky U. Bender L, et al. Eur J Pharm Sci. 2024 Mar 11;196:106748. doi: 10.1016/j.ejps.2024.106748. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38471594 Free article.

50

Population pharmacokinetic/pharmacodynamic modeling of H018, a selective JAK1 inhibitor, in healthy Chinese volunteers.

Qu Y, Zhou W, Wang M, Zhang Q, Su M, Pan J. Qu Y, et al. Eur J Pharm Sci. 2024 Mar 11;196:106747. doi: 10.1016/j.ejps.2024.106747. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38467333 Free article.

51

Environmental considerations along the life cycle of pharmaceuticals: Interview study on views regarding environmental challenges, concerns, strategies, and prospects within the pharmaceutical industry.

Riikonen S, Timonen J, Sikanen T. Riikonen S, et al. Eur J Pharm Sci. 2024 Mar 7;196:106743. doi: 10.1016/j.ejps.2024.106743. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38460610 Free article.

52

Regional lung targeting with a fluticasone/salmeterol aerosol using a bolus breath hold method of the PreciseInhale® system: A first evaluation in humans.

Gerde P, Sjöberg CO, Bäckroos H, Englund J, Wangheim M, Litorp H. Gerde P, et al. Eur J Pharm Sci. 2024 Mar 7;196:106742. doi: 10.1016/j.ejps.2024.106742. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38460609 Free article.

53

Open forum conference on the ICH M13A bioequivalence guideline.

Blume H, Wedemeyer S, Seidlitz A, Beuerle G, Klein S, Bilensoy E. Blume H, et al. Eur J Pharm Sci. 2024 Mar 5;196:106741. doi: 10.1016/j.ejps.2024.106741. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38452875 Free article. Review.

54

The 2-aminoethyl diphenylborinate-based fluorescent method identifies quercetin and luteolin metabolites as substrates of Organic anion transporting polypeptides, OATP1B1 and OATP2B1.

Kaci H, Bakos É, Needs PW, Kroon PA, Valentová K, Poór M, Özvegy-Laczka C. Kaci H, et al. Eur J Pharm Sci. 2024 Mar 2;196:106740. doi: 10.1016/j.ejps.2024.106740. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38437885 Free article.

55

Virtual special issue of Nordic POP: Patient-oriented products.

Rosenholm JM, Flaten GE, Teleki A. Rosenholm JM, et al. Eur J Pharm Sci. 2024 Mar 1:106737. doi: 10.1016/j.ejps.2024.106737. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38432548 Free article. No abstract available.

56

ProtT5 and random forests-based viscosity prediction method for therapeutic mAbs.

Hao X, Fan L. Hao X, et al. Eur J Pharm Sci. 2024 Mar 1;194:106705. doi: 10.1016/j.ejps.2024.106705. Epub 2024 Jan 19. Eur J Pharm Sci. 2024. PMID: 38246432 Free article.

57

Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy.

Chen Y, Ke M, Fang W, Jiang Y, Lin R, Wu W, Huang P, Lin C. Chen Y, et al. Eur J Pharm Sci. 2024 Mar 1;194:106707. doi: 10.1016/j.ejps.2024.106707. Epub 2024 Jan 18. Eur J Pharm Sci. 2024. PMID: 38244810 Free article.

58

Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells.

Zhang T, Zhou C, Lv M, Yu J, Cheng S, Cui X, Wan X, Ahmad M, Xu B, Qin J, Meng X, Luo H. Zhang T, et al. Eur J Pharm Sci. 2024 Mar 1;194:106706. doi: 10.1016/j.ejps.2024.106706. Epub 2024 Jan 19. Eur J Pharm Sci. 2024. PMID: 38244809 Free article.

59

Erratum to "Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays" [European Journal of Pharmaceutical Sciences 159 (2021) 105737].

Brayden DJ, Stuettgen V. Brayden DJ, et al. Eur J Pharm Sci. 2024 Mar 1;194:106698. doi: 10.1016/j.ejps.2024.106698. Epub 2024 Jan 18. Eur J Pharm Sci. 2024. PMID: 38242807 Free article. No abstract available.

60

Pitfalls in evaluating permeability experiments with Caco-2/MDCK cell monolayers.

Ebert A, Dahley C, Goss KU. Ebert A, et al. Eur J Pharm Sci. 2024 Mar 1;194:106699. doi: 10.1016/j.ejps.2024.106699. Epub 2024 Jan 16. Eur J Pharm Sci. 2024. PMID: 38232636 Free article.

61

Microparticles and multi-unit systems for advanced drug delivery.

Kállai-Szabó N, Farkas D, Lengyel M, Basa B, Fleck C, Antal I. Kállai-Szabó N, et al. Eur J Pharm Sci. 2024 Mar 1;194:106704. doi: 10.1016/j.ejps.2024.106704. Epub 2024 Jan 14. Eur J Pharm Sci. 2024. PMID: 38228279 Free article. Review.

62

Using molecularly dissolved drug concentrations in PBBMs improves the prediction of oral absorption from supersaturating formulations.

Holzem FL, Petrig Schaffland J, Brandl M, Bauer-Brandl A, Stillhart C. Holzem FL, et al. Eur J Pharm Sci. 2024 Mar 1;194:106703. doi: 10.1016/j.ejps.2024.106703. Epub 2024 Jan 14. Eur J Pharm Sci. 2024. PMID: 38224722 Free article.

63

Development of a canine artificial colonic mucus model for drug diffusion studies.

Barmpatsalou V, Tjakra M, Li L, Dubbelboer IR, Karlsson E, Pedersen Lomstein B, Bergström CAS. Barmpatsalou V, et al. Eur J Pharm Sci. 2024 Mar 1;194:106702. doi: 10.1016/j.ejps.2024.106702. Epub 2024 Jan 12. Eur J Pharm Sci. 2024. PMID: 38218203 Free article.

64

Physiologically based pharmacokinetic modeling of ritonavir-oxycodone drug interactions and its implication for dosing strategy.

Zheng L, Zhang W, Olkkola KT, Dallmann A, Ni L, Zhao Y, Wang L, Zhang Q, Hu W. Zheng L, et al. Eur J Pharm Sci. 2024 Mar 1;194:106697. doi: 10.1016/j.ejps.2024.106697. Epub 2024 Jan 8. Eur J Pharm Sci. 2024. PMID: 38199444 Free article.

65

J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice.

Pan Z, Shao M, Zhao C, Yang X, Li H, Cui G, Liang X, Yu CW, Ye Q, Gao C, Di L, Chern JW, Zhou H, Lee SM. Pan Z, et al. Eur J Pharm Sci. 2024 Mar 1;194:106696. doi: 10.1016/j.ejps.2024.106696. Epub 2024 Jan 9. Eur J Pharm Sci. 2024. PMID: 38199443 Free article.

66

Evaluation of in vitro dissolution profiles of modified-release metoprolol succinate tablets crushed using mortar and pestle technique.

Kir F, Al-Sulaiti FK, Sahin S. Kir F, et al. Eur J Pharm Sci. 2024 Mar 1;194:106694. doi: 10.1016/j.ejps.2024.106694. Epub 2024 Jan 7. Eur J Pharm Sci. 2024. PMID: 38191064 Free article.

67

Pharmacokinetics, biodistribution, and in vivo toxicity of 7-nitroindazole loaded in pegylated and non-pegylated nanoemulsions in rats.

França AP, Silva TA, Schulz D, Gomes-Pereira L, Cunha LMA, Gonçalves MP, Vieira JVS, Sanches MP, Koehler N, Maluf S, Poli A, da Silva-Santos JE, Assreuy J, Lemos-Senna E. França AP, et al. Eur J Pharm Sci. 2024 Mar 1;194:106695. doi: 10.1016/j.ejps.2024.106695. Epub 2024 Jan 7. Eur J Pharm Sci. 2024. PMID: 38191063 Free article.

68

Aerosol delivery and spatiotemporal tissue distribution of hydroxychloroquine in rat lung.

Xia W, Kolli AR, Kuczaj AK, Szostak J, Lam S, Toh WW, Purwanti A, Tan WT, Ng R, Phillips B, Peitsch MC, Hoeng J. Xia W, et al. Eur J Pharm Sci. 2024 Mar 1;194:106693. doi: 10.1016/j.ejps.2024.106693. Epub 2024 Jan 4. Eur J Pharm Sci. 2024. PMID: 38184016 Free article.

69

Antiplatelet activity and toxicity profile of novel phosphonium salts derived from Michael reaction.

Haffouz A, Elleuch H, Khemakhem B, Ben Amor I, Jerbi A, Gargouri J, Sahli E, Mhadhbi N, Ghalla H, Rezgui F, Gargouri A, HadjKacem B. Haffouz A, et al. Eur J Pharm Sci. 2024 Mar 1;194:106692. doi: 10.1016/j.ejps.2024.106692. Epub 2024 Jan 4. Eur J Pharm Sci. 2024. PMID: 38181870 Free article.

70

Enhancement of the solubility and oral bioavailability of altrenogest through complexation with hydroxypropyl-β-cyclodextrin.

Chen W, Zheng X, Lao W, Wang H, Chen S, Liu C, Chen Z, Bai Y, Zhang H, Zhan X, Wang B. Chen W, et al. Eur J Pharm Sci. 2024 Mar 1;194:106691. doi: 10.1016/j.ejps.2024.106691. Epub 2024 Jan 4. Eur J Pharm Sci. 2024. PMID: 38181869 Free article.

71

Exploring the impact of CYP2D6 and UGT2B7 gene-drug interactions, and CYP-mediated DDI on oxycodone and oxymorphone pharmacokinetics using physiologically-based pharmacokinetic modeling and simulation.

Klose M, Cristofoletti R, Silva CM, Mangal N, Turgeon J, Michaud V, Lesko LJ, Schmidt S. Klose M, et al. Eur J Pharm Sci. 2024 Mar 1;194:106689. doi: 10.1016/j.ejps.2023.106689. Epub 2024 Jan 1. Eur J Pharm Sci. 2024. PMID: 38171419 Free article.

72

Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations.

Ejskjær L, O'Dwyer PJ, Ryan CD, Holm R, Kuentz M, Box KJ, Griffin BT. Ejskjær L, et al. Eur J Pharm Sci. 2024 Mar 1;194:106681. doi: 10.1016/j.ejps.2023.106681. Epub 2023 Dec 20. Eur J Pharm Sci. 2024. PMID: 38128839 Free article.

73

Investigation into the impact of proton pump inhibitors on sertraline transport across the blood-brain barrier.

Xiao Y, Xu W, Niu D, Quan Z, Wang L. Xiao Y, et al. Eur J Pharm Sci. 2024 Mar 1;194:106653. doi: 10.1016/j.ejps.2023.106653. Epub 2023 Nov 24. Eur J Pharm Sci. 2024. PMID: 38006986 Free article.

74

Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes - detailed studies on CYP3A inhibitors.

Kahma H, Paludetto MN, Neuvonen M, Kurkela M, Filppula AM, Niemi M, Backman JT. Kahma H, et al. Eur J Pharm Sci. 2024 Feb 27:106735. doi: 10.1016/j.ejps.2024.106735. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38423227 Free article.

75

Microfluidics produced ATRA-loaded PLGA NPs reduced tuberculosis burden in alveolar epithelial cells and enabled high delivered dose under simulated human breathing pattern in 3D printed head models.

Bahlool AZ, Cavanagh B, Sullivan AO, MacLoughlin R, Keane J, Sullivan MPO, Cryan SA. Bahlool AZ, et al. Eur J Pharm Sci. 2024 Feb 26;196:106734. doi: 10.1016/j.ejps.2024.106734. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38417586 Free article.

76

Miniaturized screening and performance prediction of tailored subcutaneous extended-release formulations for preclinical in vivo studies.

Block M, Sieger P, Truenkle C, Saal C, Simon R, Truebenbach I. Block M, et al. Eur J Pharm Sci. 2024 Feb 24;196:106733. doi: 10.1016/j.ejps.2024.106733. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38408709 Free article.

77

Development and characterization of solid lipid-based formulations (sLBFs) of ritonavir utilizing a lipolysis and permeation assay.

Schulzen A, Andreadis II, Bergström CAS, Quodbach J. Schulzen A, et al. Eur J Pharm Sci. 2024 Feb 24;196:106732. doi: 10.1016/j.ejps.2024.106732. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38408708 Free article.

78

Management of oxidative stress for cell therapy through combinational approaches of stem cells, antioxidants, and photobiomodulation.

Asgari R, Mehran YZ, Weber HM, Weber M, Golestanha SA, Hosseini Kazerouni SM, Panahi F, Mohammadi P, Mansouri K. Asgari R, et al. Eur J Pharm Sci. 2024 Feb 1;196:106715. doi: 10.1016/j.ejps.2024.106715. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 38301971 Free article. Review.

79

Communication between nonalcoholic fatty liver disease and atherosclerosis: Focusing on exosomes.

Zhao X, Kong X, Cui Z, Zhang Z, Wang M, Liu G, Gao H, Zhang J, Qin W. Zhao X, et al. Eur J Pharm Sci. 2024 Feb 1;193:106690. doi: 10.1016/j.ejps.2024.106690. Epub 2024 Jan 3. Eur J Pharm Sci. 2024. PMID: 38181871 Free article. Review.

80

IGF-PLGA microspheres promote angiogenesis and accelerate skin flap repair and healing by inhibiting oxidative stress and regulating the Ang 1/Tie 2 signaling pathway.

Hu F, Huang K, Zhang H, Hu W, Tong S, Xu H. Hu F, et al. Eur J Pharm Sci. 2024 Feb 1;193:106687. doi: 10.1016/j.ejps.2023.106687. Epub 2024 Jan 2. Eur J Pharm Sci. 2024. PMID: 38176662 Free article.

81

Recent advances and clinical translation of liposomal delivery systems in cancer therapy.

Chen J, Hu S, Sun M, Shi J, Zhang H, Yu H, Yang Z. Chen J, et al. Eur J Pharm Sci. 2024 Feb 1;193:106688. doi: 10.1016/j.ejps.2023.106688. Epub 2024 Jan 1. Eur J Pharm Sci. 2024. PMID: 38171420 Free article. Review.

82

Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation.

Belhadj Z, Offei S, Jacobson BA, Cambron D, Kratzke RA, Wang Z, Xie J. Belhadj Z, et al. Eur J Pharm Sci. 2024 Feb 1;193:106686. doi: 10.1016/j.ejps.2023.106686. Epub 2023 Dec 29. Eur J Pharm Sci. 2024. PMID: 38159687 Free article.

83

A comparison of USP 2 and µDISS Profiler™ apparatus for studying dissolution phenomena of ibuprofen and its salts.

Zöller L, Avdeef A, Karlsson E, Borde A, Carlert S, Saal C, Dressman J. Zöller L, et al. Eur J Pharm Sci. 2024 Feb 1;193:106684. doi: 10.1016/j.ejps.2023.106684. Epub 2023 Dec 26. Eur J Pharm Sci. 2024. PMID: 38154507 Free article.

84

Construction of chrysophanol loaded nanoparticles with N-octyl-O-sulfate chitosan for enhanced nephroprotective effect.

Wei Q, Gao F, Gao L, Gao H, Zhang J, Bao R, Zhang H, Wang J, Shen Q, Gu M. Wei Q, et al. Eur J Pharm Sci. 2024 Feb 1;193:106685. doi: 10.1016/j.ejps.2023.106685. Epub 2023 Dec 27. Eur J Pharm Sci. 2024. PMID: 38154506 Free article.

85

Assessing the performance of new chromatographic technologies for the separation of peptide epimeric impurities: the case of Icatibant.

Mazzoccanti G, Manetto S, Bassan M, Macis M, Cabri W, Ciogli A, Ricci A, Gasparrini F. Mazzoccanti G, et al. Eur J Pharm Sci. 2024 Feb 1;193:106682. doi: 10.1016/j.ejps.2023.106682. Epub 2023 Dec 22. Eur J Pharm Sci. 2024. PMID: 38142950 Free article.

86

Formulation optimization and evaluation of oromucosal in situ gel loaded with silver nanoparticles prepared by green biosynthesis.

Rohaľová S, Wolaschka T, Balážová Ľ, Paulovičová K, Tóthová J, Pavloková S, Stahorský M, Gajdziok J. Rohaľová S, et al. Eur J Pharm Sci. 2024 Feb 1;193:106683. doi: 10.1016/j.ejps.2023.106683. Epub 2023 Dec 22. Eur J Pharm Sci. 2024. PMID: 38142949 Free article.

87

Tetramethylpyrazine-loaded liposomes surrounded by hydrogel based on sodium alginate and chitosan as a multifunctional drug delivery System for treatment of atopic dermatitis.

Xia Y, Cao K, Jia R, Chen X, Wu Y, Wang Y, Cheng Z, Xia H, Xu Y, Xie Z. Xia Y, et al. Eur J Pharm Sci. 2024 Feb 1;193:106680. doi: 10.1016/j.ejps.2023.106680. Epub 2023 Dec 19. Eur J Pharm Sci. 2024. PMID: 38128842 Free article.

88

The effect of mixing on the dispersibility of adhesive mixtures for inhalation. Comparison of high shear and Turbula mixers.

Thalberg K, Ivarsson L, Svensson M, Elfman P, Ohlsson A, Stuckel J, Lyberg AM. Thalberg K, et al. Eur J Pharm Sci. 2024 Feb 1;193:106679. doi: 10.1016/j.ejps.2023.106679. Epub 2023 Dec 20. Eur J Pharm Sci. 2024. PMID: 38128841 Free article.

89

Peptides targeting the BTLA-HVEM complex can modulate T cell immune response.

Wojciechowicz K, Kuncewicz K, Lisowska KA, Wardowska A, Spodzieja M. Wojciechowicz K, et al. Eur J Pharm Sci. 2024 Feb 1;193:106677. doi: 10.1016/j.ejps.2023.106677. Epub 2023 Dec 20. Eur J Pharm Sci. 2024. PMID: 38128840 Free article.

90

Harmonizing the craft of crafting clinically endorsed small-molecule BCR-ABL tyrosine kinase inhibitors for the treatment of hematological malignancies.

Sun L, Yang PC, Luan L, Sun JF, Wang YT. Sun L, et al. Eur J Pharm Sci. 2024 Feb 1;193:106678. doi: 10.1016/j.ejps.2023.106678. Epub 2023 Dec 17. Eur J Pharm Sci. 2024. PMID: 38114052 Free article. Review.

91

¹⁸F-labeled somatostatin analogs for somatostatin receptors (SSTRs) targeted PET imaging of neuroendocrine tumors (NETs).

Gao F, Zhang Y, Chen M, Song Z, Dong R, Qiu S, Shen C, Huang X, Geng H, Cheng W, Hu J. Gao F, et al. Eur J Pharm Sci. 2024 Feb 1;193:106671. doi: 10.1016/j.ejps.2023.106671. Epub 2023 Dec 16. Eur J Pharm Sci. 2024. PMID: 38104907 Free article.

92

High-throughput virtual screening to identify potential small molecule inhibitors of the Zα domain of the adenosine deaminases acting on RNA 1(ADAR1).

Hong X, Wei Z, He L, Bu Q, Wu G, Chen G, He W, Deng Q, Huang S, Huang Y, Yu C, Luo X, Lin Y. Hong X, et al. Eur J Pharm Sci. 2024 Feb 1;193:106672. doi: 10.1016/j.ejps.2023.106672. Epub 2023 Dec 14. Eur J Pharm Sci. 2024. PMID: 38103658 Free article.

93

Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.

Guareschi F, Del Favero E, Ricci C, Cantù L, Brandolini M, Sambri V, Nicoli S, Pescina S, D'Angelo D, Rossi I, Buttini F, Bettini R, Sonvico F. Guareschi F, et al. Eur J Pharm Sci. 2024 Feb 1;193:106673. doi: 10.1016/j.ejps.2023.106673. Epub 2023 Dec 14. Eur J Pharm Sci. 2024. PMID: 38103657 Free article.

94

Formulation and investigation of hydrogels containing an increased level of diclofenac sodium using risk assessment tools.

Kovács A, Falusi F, Gácsi A, Budai-Szűcs M, Csányi E, Veréb Z, Monostori T, Csóka I, Berkó S. Kovács A, et al. Eur J Pharm Sci. 2024 Feb 1;193:106666. doi: 10.1016/j.ejps.2023.106666. Epub 2023 Dec 10. Eur J Pharm Sci. 2024. PMID: 38081373 Free article.

95

Population pharmacokinetics of methotrexate and 7-hydroxymethotrexate and delayed excretion in infants and young children with brain tumors.

Campagne O, Huang J, Lin T, Reddick WE, Selvo NS, Onar-Thomas A, Ward D, Robinson G, Gajjar A, Stewart CF. Campagne O, et al. Eur J Pharm Sci. 2024 Feb 1;193:106669. doi: 10.1016/j.ejps.2023.106669. Epub 2023 Dec 8. Eur J Pharm Sci. 2024. PMID: 38070781 Free PMC article.

96

Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma.

Pareek A, Kothari R, Pareek A, Ratan Y, Kashania P, Jain V, Jeandet P, Kumar P, Khan AA, Alanazi AM, Gupta MM. Pareek A, et al. Eur J Pharm Sci. 2024 Feb 1;193:106642. doi: 10.1016/j.ejps.2023.106642. Epub 2023 Nov 15. Eur J Pharm Sci. 2024. PMID: 37977235 Free article.

97

The effect of polymeric binder type and concentration on flow and dissolution properties of SMEDDS loaded mesoporous silica-based granules.

Kovačević M, Zvonar Pobirk A, German Ilić I. Kovačević M, et al. Eur J Pharm Sci. 2024 Feb 1;193:106582. doi: 10.1016/j.ejps.2023.106582. Epub 2023 Sep 12. Eur J Pharm Sci. 2024. PMID: 37709174 Free article.

98

Infliximab aggregates produced in severe and mild elevated temperature stress conditions induce an extended specific CD4 T-cell response.

Nabhan M, Meunier S, Le-Minh V, Robin B, de Bourayne M, Smadja C, Maillère B, Pallardy M, Turbica I. Nabhan M, et al. Eur J Pharm Sci. 2024 Jan 1;192:106670. doi: 10.1016/j.ejps.2023.106670. Epub 2023 Dec 8. Eur J Pharm Sci. 2024. PMID: 38070782 Free article.

99

In vitro trypanocidal potency and in vivo treatment efficacy of oligomeric ethylene glycol-tethered nitrofurantoin derivatives.

Janse van Rensburg HD, N'Da DD, Suganuma K. Janse van Rensburg HD, et al. Eur J Pharm Sci. 2024 Jan 1;192:106668. doi: 10.1016/j.ejps.2023.106668. Epub 2023 Dec 7. Eur J Pharm Sci. 2024. PMID: 38065268 Free article.

100

Folic acid-functionalized chitosan nanoparticles with bioenzyme activity for the treatment of spinal cord injury.

Li Y, Zou Z, An J, Liu X, Wu Q, Sun J, Liu X, Du J, Xiong Y, Wu C, Mei X, Tian H. Li Y, et al. Eur J Pharm Sci. 2024 Jan 1;192:106667. doi: 10.1016/j.ejps.2023.106667. Epub 2023 Dec 6. Eur J Pharm Sci. 2024. PMID: 38061663 Free article.

101

Preparation of paeoniflorin-glycyrrhizic acid complex transethosome gel and its preventive and therapeutic effects on melasma.

Xiao Y, Zhou L, Tao W, Yang X, Li J, Wang R, Zhao Y, Peng C, Zhang C. Xiao Y, et al. Eur J Pharm Sci. 2024 Jan 1;192:106664. doi: 10.1016/j.ejps.2023.106664. Epub 2023 Dec 5. Eur J Pharm Sci. 2024. PMID: 38061662 Free article.

102

A first-in-human study of Brozopentyl Sodium, following single and multiple ascending intravenous infusion in Chinese healthy volunteers.

Sheng XY, Xie R, Wei LH, Jia B, Li YF, Zheng ZG, Zhao X, Cui YM. Sheng XY, et al. Eur J Pharm Sci. 2024 Jan 1;192:106663. doi: 10.1016/j.ejps.2023.106663. Epub 2023 Dec 5. Eur J Pharm Sci. 2024. PMID: 38056780 Free article. Clinical Trial.

103

Gellan gum-based bi-polymeric hydrogel scaffolds loaded with Rosuvastatin calcium: A useful tool for tendon tissue regeneration.

Adel IM, ElMeligy MF, Amer MS, Elkasabgy NA. Adel IM, et al. Eur J Pharm Sci. 2024 Jan 1;192:106659. doi: 10.1016/j.ejps.2023.106659. Epub 2023 Dec 3. Eur J Pharm Sci. 2024. PMID: 38052258 Free article.

104

Design, synthesis and bioevaluation of novel prenylated chalcones derivatives as potential antitumor agents.

Yu J, Wang X, Cheng S, Zeng X, Wan X, Wei S, Xu B, Luo H, Meng X. Yu J, et al. Eur J Pharm Sci. 2024 Jan 1;192:106660. doi: 10.1016/j.ejps.2023.106660. Epub 2023 Dec 3. Eur J Pharm Sci. 2024. PMID: 38052256 Free article.

105

In vitro and in vivo pharmacokinetics, disposition, and drug-drug interaction potential of tinengotinib (TT-00420), a promising investigational drug for treatment of cholangiocarcinoma and other solid tumors.

Ni S, Li L, Sun X, Wang Y, Yu Q, Wang W, Gu Z, Yu Z, Wu D, Wu F, Jiang S, Peng P. Ni S, et al. Eur J Pharm Sci. 2024 Jan 1;192:106658. doi: 10.1016/j.ejps.2023.106658. Epub 2023 Dec 2. Eur J Pharm Sci. 2024. PMID: 38048851 Free article.

106

Evaluation of the impact of tragacanth/xanthan gum interpolymer complexation with chitosan on pharmaceutical performance of gels with secnidazole as potential periodontal treatment.

Potaś J, Wach RA, Rokita B, Wróblewska M, Winnicka K. Potaś J, et al. Eur J Pharm Sci. 2024 Jan 1;192:106657. doi: 10.1016/j.ejps.2023.106657. Epub 2023 Nov 30. Eur J Pharm Sci. 2024. PMID: 38040098 Free article.

107

In-house CHO HCPs platform: A promising approach for HCPs ELISA monitoring.

Giordano E, Liori B, Cecchini I, Verani R, Leone L. Giordano E, et al. Eur J Pharm Sci. 2024 Jan 1;192:106656. doi: 10.1016/j.ejps.2023.106656. Epub 2023 Nov 27. Eur J Pharm Sci. 2024. PMID: 38029932 Free article.

108

Overcoming drug impurity challenges in amorphous solid dispersion with rational development of biorelevant dissolution-permeation method.

Huzjak T, Jakasanovski O, Berginc K, Puž V, Zajc-Kreft K, Jeraj Ž, Janković B. Huzjak T, et al. Eur J Pharm Sci. 2024 Jan 1;192:106655. doi: 10.1016/j.ejps.2023.106655. Epub 2023 Nov 26. Eur J Pharm Sci. 2024. PMID: 38016626 Free article.

109

In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692.

Dömötör O, Mathuber M, Kowol CR. Dömötör O, et al. Eur J Pharm Sci. 2024 Jan 1;192:106651. doi: 10.1016/j.ejps.2023.106651. Epub 2023 Nov 25. Eur J Pharm Sci. 2024. PMID: 38013124 Free article.

110

Development and characterization of a spray-dried inhalable ternary combination for the treatment of Pseudomonas aeruginosa biofilm infection in cystic fibrosis.

Alhajj N, Yahya MFZR, O'Reilly NJ, Cathcart H. Alhajj N, et al. Eur J Pharm Sci. 2024 Jan 1;192:106654. doi: 10.1016/j.ejps.2023.106654. Epub 2023 Nov 25. Eur J Pharm Sci. 2024. PMID: 38013123 Free article.

111

A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics.

Kassem AM, Almukainzi M, Faris TM, Ibrahim AH, Anwar W, Elbahwy IA, El-Gamal FR, Zidan MF, Akl MA, Abd-ElGawad AM, Elshamy AI, Elmowafy M. Kassem AM, et al. Eur J Pharm Sci. 2024 Jan 1;192:106652. doi: 10.1016/j.ejps.2023.106652. Epub 2023 Nov 25. Eur J Pharm Sci. 2024. PMID: 38008226 Free article.

112

The use of polymorphic state modifiers in solid lipid microparticles: The role of structural modifications on drug release performance.

Bertoni S, Simone E, Sangiorgi S, Albertini B, Passerini N. Bertoni S, et al. Eur J Pharm Sci. 2024 Jan 1;192:106650. doi: 10.1016/j.ejps.2023.106650. Epub 2023 Nov 22. Eur J Pharm Sci. 2024. PMID: 37995834 Free article.

113

A comprehensively validated IVRT method reliably discriminates sameness and differences between several topical clotrimazole creams.

Wellington H, Rath S, Kanfer I. Wellington H, et al. Eur J Pharm Sci. 2024 Jan 1;192:106649. doi: 10.1016/j.ejps.2023.106649. Epub 2023 Nov 21. Eur J Pharm Sci. 2024. PMID: 37992910 Free article.

114

Fibrous matrices facilitate pleurocidin killing of wound associated bacterial pathogens.

Ramos C, Lorenz K, Putrinš M, Hind CK, Meos A, Laidmäe I, Tenson T, Sutton JM, Mason AJ, Kogermann K. Ramos C, et al. Eur J Pharm Sci. 2024 Jan 1;192:106648. doi: 10.1016/j.ejps.2023.106648. Epub 2023 Nov 21. Eur J Pharm Sci. 2024. PMID: 37992909 Free article.

115

In Vitro and In Vivo Evaluation of Dark Chocolate as Age-appropriate Oral Matrix.

Al-Kabariti AY, Arafat BT, Oriquat GA, Možná P, Jaidy H, Rehmani A, Patel K, Al-Qinna N, Alhnan MA. Al-Kabariti AY, et al. Eur J Pharm Sci. 2024 Jan 1;192:106646. doi: 10.1016/j.ejps.2023.106646. Epub 2023 Nov 19. Eur J Pharm Sci. 2024. PMID: 37989467 Free article.

116

Towards personalized drug delivery via semi-solid extrusion: Exploring poly(vinyl alcohol-co-vinyl acetate) copolymers for hydrochlorothiazide-loaded films.

Korelc K, Larsen BS, Heintze AL, Henrik-Klemens Å, Karlsson J, Larsson A, Tho I. Korelc K, et al. Eur J Pharm Sci. 2024 Jan 1;192:106645. doi: 10.1016/j.ejps.2023.106645. Epub 2023 Nov 18. Eur J Pharm Sci. 2024. PMID: 37984596 Free article.

117

Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases.

Zhao Y, Wang H, Jin L, Zhang Z, Liu L, Zhou M, Zhang X, Zhang L. Zhao Y, et al. Eur J Pharm Sci. 2024 Jan 1;192:106647. doi: 10.1016/j.ejps.2023.106647. Epub 2023 Nov 18. Eur J Pharm Sci. 2024. PMID: 37984595 Free article. Review.

118

A randomized double-blind phase Ib clinical trial of SY-009 in patients with type 2 diabetes mellitus.

Huang L, Cao B, Geng Y, Zhou X, Yang Y, Ma T, Lin H, Huang Z, Zhuo L, Li J. Huang L, et al. Eur J Pharm Sci. 2024 Jan 1;192:106644. doi: 10.1016/j.ejps.2023.106644. Epub 2023 Nov 20. Eur J Pharm Sci. 2024. PMID: 37981049 Free article. Clinical Trial.

119

Do the enantiomers of ketamine bind enantioselectively to human serum albumin?

Schmidt S, Holzgrabe U. Schmidt S, et al. Eur J Pharm Sci. 2024 Jan 1;192:106640. doi: 10.1016/j.ejps.2023.106640. Epub 2023 Nov 18. Eur J Pharm Sci. 2024. PMID: 37979888 Free article.

120

Salvianolic acid B-loaded polydopamine-modified hollow mesoporous organic silica nanoparticles for treatment of breast cancer metastasis via suppressing cancer-associated fibroblasts.

Hu M, Cheng N, Wang S, Li R, Liu Y, Wang L, Chen W, Chen Y. Hu M, et al. Eur J Pharm Sci. 2024 Jan 1;192:106641. doi: 10.1016/j.ejps.2023.106641. Epub 2023 Nov 14. Eur J Pharm Sci. 2024. PMID: 37972905 Free article.

121

Analysis of stabilization mechanisms in β-lactoglobulin-based amorphous solid dispersions by experimental and computational approaches.

Zhuo X, Foderà V, Larsson P, Schaal Z, Bergström CAS, Löbmann K, Kabedev A. Zhuo X, et al. Eur J Pharm Sci. 2024 Jan 1;192:106639. doi: 10.1016/j.ejps.2023.106639. Epub 2023 Nov 13. Eur J Pharm Sci. 2024. PMID: 37967658 Free article.

122

Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment.

Passos JS, Apolinario AC, Ishida K, Martins TS, Lopes LB. Passos JS, et al. Eur J Pharm Sci. 2024 Jan 1;192:106638. doi: 10.1016/j.ejps.2023.106638. Epub 2023 Nov 13. Eur J Pharm Sci. 2024. PMID: 37967657 Free article.

123

Altering distribution profile of palbociclib by its prodrugs.

Järvinen J, Montaser AB, Adla SK, Leppänen J, Lehtonen M, Vellonen KS, Laitinen T, Jalkanen A, Elmquist WF, Timonen J, Huttunen KM, Rautio J. Järvinen J, et al. Eur J Pharm Sci. 2024 Jan 1;192:106637. doi: 10.1016/j.ejps.2023.106637. Epub 2023 Nov 13. Eur J Pharm Sci. 2024. PMID: 37967656 Free article.

124

Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase.

Miguel RDA, Hirata AS, Salata GC, Apolinário AC, Barroso VM, Ishida K, La Clair JJ, Fenical W, Martins TS, Costa-Lotufo LV, Lopes LB. Miguel RDA, et al. Eur J Pharm Sci. 2024 Jan 1;192:106635. doi: 10.1016/j.ejps.2023.106635. Epub 2023 Nov 11. Eur J Pharm Sci. 2024. PMID: 37952683 Free article.

125

A robust analytical method for simultaneous quantification of 13 low-molecular-weight N-Nitrosamines in various pharmaceuticals based on solid phase extraction and liquid chromatography coupled to high-resolution mass spectrometry.

Planinšek Parfant T, Skube T, Roškar R. Planinšek Parfant T, et al. Eur J Pharm Sci. 2024 Jan 1;192:106633. doi: 10.1016/j.ejps.2023.106633. Epub 2023 Nov 10. Eur J Pharm Sci. 2024. PMID: 37951317 Free article.

126

Preparation of polycaprolactone and polymethacrylate nanofibers for controlled ocular delivery of ketorolac tromethamine: Pharmacokinetic study in Rabbit's Eye.

Taghe S, Mirzaeei S, Bagheri M. Taghe S, et al. Eur J Pharm Sci. 2024 Jan 1;192:106631. doi: 10.1016/j.ejps.2023.106631. Epub 2023 Nov 10. Eur J Pharm Sci. 2024. PMID: 37951316 Free article.

127

Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.

Paulus F, Bauer-Brandl A, Stappaerts J, Holm R. Paulus F, et al. Eur J Pharm Sci. 2024 Jan 1;192:106634. doi: 10.1016/j.ejps.2023.106634. Epub 2023 Nov 10. Eur J Pharm Sci. 2024. PMID: 37951315 Free article.

128

A comprehensive review of advanced nasal delivery: Specially insulin and calcitonin.

Luo D, Ni X, Yang H, Feng L, Chen Z, Bai L. Luo D, et al. Eur J Pharm Sci. 2024 Jan 1;192:106630. doi: 10.1016/j.ejps.2023.106630. Epub 2023 Nov 9. Eur J Pharm Sci. 2024. PMID: 37949195 Free article. Review.

129

The overview of development of novel bacterial topoisomerase inhibitors effective against multidrug-resistant bacteria in an academic environment: From early hits to in vivo active antibacterials.

Zorman M, Hrast Rambaher M, Kokot M, Minovski N, Anderluh M. Zorman M, et al. Eur J Pharm Sci. 2024 Jan 1;192:106632. doi: 10.1016/j.ejps.2023.106632. Epub 2023 Nov 9. Eur J Pharm Sci. 2024. PMID: 37949194 Free article. Review.

130

Stabilization effects of saccharides in protein formulations: A review of sucrose, trehalose, cyclodextrins and dextrans.

Li J, Wang H, Wang L, Yu D, Zhang X. Li J, et al. Eur J Pharm Sci. 2024 Jan 1;192:106625. doi: 10.1016/j.ejps.2023.106625. Epub 2023 Nov 2. Eur J Pharm Sci. 2024. PMID: 37918545 Free article. Review.

131

Novel nanomicelle butenafine formulation for ocular drug delivery against fungal keratitis: In Vitro and In Vivo study.

Lu P, Liang Z, Zhang Z, Yang J, Song F, Zhou T, Li J, Zhang J. Lu P, et al. Eur J Pharm Sci. 2024 Jan 1;192:106629. doi: 10.1016/j.ejps.2023.106629. Epub 2023 Nov 2. Eur J Pharm Sci. 2024. PMID: 37918544 Free article.

132

Proteolysis Targeting Chimeras (PROTACs) based on celastrol induce multiple protein degradation for triple-negative breast cancer treatment.

Gan X, Wang F, Luo J, Zhao Y, Wang Y, Yu C, Chen J. Gan X, et al. Eur J Pharm Sci. 2024 Jan 1;192:106624. doi: 10.1016/j.ejps.2023.106624. Epub 2023 Oct 28. Eur J Pharm Sci. 2024. PMID: 37898394 Free article.

133

Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study.

Zhang T, Tao Y, Pu J, Zhu M, Wan L, Tang C. Zhang T, et al. Eur J Pharm Sci. 2024 Jan 1;192:106621. doi: 10.1016/j.ejps.2023.106621. Epub 2023 Oct 28. Eur J Pharm Sci. 2024. PMID: 37898393 Free article. Clinical Trial.

134

The prescription design and key properties of nasal gel for CNS drug delivery: A review.

Wang M, Ma X, Zong S, Su Y, Su R, Zhang H, Liu Y, Wang C, Li Y. Wang M, et al. Eur J Pharm Sci. 2024 Jan 1;192:106623. doi: 10.1016/j.ejps.2023.106623. Epub 2023 Oct 26. Eur J Pharm Sci. 2024. PMID: 37890640 Free article. Review.

135

Bicarbonate buffer dissolution test with gentle mechanistic stress for bioequivalence prediction of enteric-coated pellet formulations.

Ikuta S, Nakagawa H, Kai T, Sugano K. Ikuta S, et al. Eur J Pharm Sci. 2024 Jan 1;192:106622. doi: 10.1016/j.ejps.2023.106622. Epub 2023 Oct 24. Eur J Pharm Sci. 2024. PMID: 37884100 Free article.

136

Enhancing both oral bioavailability and anti-ischemic stroke efficacy of ginkgolide B by preparing nanocrystals self-stabilized Pickering nano-emulsion.

Liu Y, Zhang C, Cheng L, Wang H, Lu M, Xu H. Liu Y, et al. Eur J Pharm Sci. 2024 Jan 1;192:106620. doi: 10.1016/j.ejps.2023.106620. Epub 2023 Oct 21. Eur J Pharm Sci. 2024. PMID: 37871688 Free article.

137

Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets.

Larsen BS, Kissi E, Nogueira LP, Genina N, Tho I. Larsen BS, et al. Eur J Pharm Sci. 2024 Jan 1;192:106619. doi: 10.1016/j.ejps.2023.106619. Epub 2023 Oct 21. Eur J Pharm Sci. 2024. PMID: 37866675 Free article.

138

Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes.

Šmid A, Štajdohar M, Milek M, Urbančič D, Karas Kuželički N, Tamm R, Metspalu A, Mlinarič-Raščan I. Šmid A, et al. Eur J Pharm Sci. 2024 Jan 1;192:106616. doi: 10.1016/j.ejps.2023.106616. Epub 2023 Oct 19. Eur J Pharm Sci. 2024. PMID: 37865284 Free article.

139

Preparation, properties and in vitro osteogensis of self-reinforcing injectable hydrogel.

Wu H, Zhang X, Wang Z, Chen X, Li Y, Fang J, Zheng S, Zhang L, Li C, Hao L. Wu H, et al. Eur J Pharm Sci. 2024 Jan 1;192:106617. doi: 10.1016/j.ejps.2023.106617. Epub 2023 Oct 19. Eur J Pharm Sci. 2024. PMID: 37865283 Free article.

140

Development of a tadalafil transdermal formulation and evaluation of its ability to in vitro transdermal permeate using Strat-M® membrane.

Sohn JS, Choi JS. Sohn JS, et al. Eur J Pharm Sci. 2024 Jan 1;192:106615. doi: 10.1016/j.ejps.2023.106615. Epub 2023 Oct 18. Eur J Pharm Sci. 2024. PMID: 37863443 Free article.

141

Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development.

Puhlmann N, Vidaurre R, Kümmerer K. Puhlmann N, et al. Eur J Pharm Sci. 2024 Jan 1;192:106614. doi: 10.1016/j.ejps.2023.106614. Epub 2023 Oct 17. Eur J Pharm Sci. 2024. PMID: 37858896 Free article.

142

Ultrasound-guided periadventitial administration of rapamycin-fibrin glue attenuates neointimal hyperplasia in the rat carotid artery injury model.

Qiao Z, Wang F, Han D, Zhuang Y, Jiang Q, Zhang Y, Liu M, An Q, Wang Z, Shen D. Qiao Z, et al. Eur J Pharm Sci. 2024 Jan 1;192:106610. doi: 10.1016/j.ejps.2023.106610. Epub 2023 Oct 16. Eur J Pharm Sci. 2024. PMID: 37852309 Free article.

143

Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin-Farnesol) as a local drug delivery system.

de Dios-Pérez I, González-Garcinuño Á, Tabernero A, Blanco-López M, García-Esteban JA, Moreno-Rodilla V, Curto B, Pérez-Esteban P, Martín Del Valle EM. de Dios-Pérez I, et al. Eur J Pharm Sci. 2023 Dec 1;191:106618. doi: 10.1016/j.ejps.2023.106618. Epub 2023 Oct 20. Eur J Pharm Sci. 2023. PMID: 37866674 Free article.

144

Toltrazuril alkalizer-modifying solid dispersions against Toxoplasma gondii: A pharmacotechnical strategy to improve the efficacy of the drug.

Sun W, Wang B, Wang P, Liu B, Yan A, Pan B. Sun W, et al. Eur J Pharm Sci. 2023 Dec 1;191:106613. doi: 10.1016/j.ejps.2023.106613. Epub 2023 Oct 18. Eur J Pharm Sci. 2023. PMID: 37863442 Free article.

145

Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: A comprehensive in-vitro and in-vivo evaluation.

Hatem S, El-Kayal M. Hatem S, et al. Eur J Pharm Sci. 2023 Dec 1;191:106612. doi: 10.1016/j.ejps.2023.106612. Epub 2023 Oct 15. Eur J Pharm Sci. 2023. PMID: 37848153 Free article.

146

Image-based simultaneous particle size distribution and concentration measurement of powder blend components with deep learning and machine vision.

Ficzere M, Péterfi O, Farkas A, Nagy ZK, Galata DL. Ficzere M, et al. Eur J Pharm Sci. 2023 Dec 1;191:106611. doi: 10.1016/j.ejps.2023.106611. Epub 2023 Oct 15. Eur J Pharm Sci. 2023. PMID: 37844806 Free article.

147

A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide.

Glieca S, Cavazzini D, Levati E, Garrapa V, Bolchi A, Franceschi V, Odau S, Ottonello S, Donofrio G, Füner J, Sonvico F, Bettini R, Montanini B, Buttini F. Glieca S, et al. Eur J Pharm Sci. 2023 Dec 1;191:106609. doi: 10.1016/j.ejps.2023.106609. Epub 2023 Oct 13. Eur J Pharm Sci. 2023. PMID: 37838239 Free article.

148

Influence of mesh nebulizer characteristics on aerosol delivery in non-human primates.

Cabrera M, Le Pennec D, Le Guellec S, Pardessus J, Ehrmann S, MacLoughlin R, Heuzé-Vourc'h N, Vecellio L. Cabrera M, et al. Eur J Pharm Sci. 2023 Dec 1;191:106606. doi: 10.1016/j.ejps.2023.106606. Epub 2023 Oct 11. Eur J Pharm Sci. 2023. PMID: 37832856 Free article.

149

Preconditioning of exosomes derived from human olfactory ensheathing cells improved motor coordination and balance in an SCA3/MJD mouse model: A new therapeutic approach.

Chen YS, Harn HJ, Hong ZX, Huang YC, Lin YT, Zheng HX, Chen PY, Yang HH, Chen PR, Tsai HC, Lin SZ, Ho TJ, Chiou TW. Chen YS, et al. Eur J Pharm Sci. 2023 Dec 1;191:106608. doi: 10.1016/j.ejps.2023.106608. Epub 2023 Oct 11. Eur J Pharm Sci. 2023. PMID: 37832855 Free article.

150

Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues.

Hammid A, Fallon JK, Vellonen KS, Lassila T, Reinisalo M, Urtti A, Gonzalez F, Tolonen A, Smith PC, Honkakoski P. Hammid A, et al. Eur J Pharm Sci. 2023 Dec 1;191:106603. doi: 10.1016/j.ejps.2023.106603. Epub 2023 Oct 11. Eur J Pharm Sci. 2023. PMID: 37827455 Free article.

151

Kiwi-derived extracellular vesicles for oral delivery of sorafenib.

Fang Z, Song M, Lai K, Cui M, Yin M, Liu K. Fang Z, et al. Eur J Pharm Sci. 2023 Dec 1;191:106604. doi: 10.1016/j.ejps.2023.106604. Epub 2023 Oct 12. Eur J Pharm Sci. 2023. PMID: 37821012 Free article.

152

Benefits and challenges of electronic package leaflet (ePL) - review of ePL pilots in hospital settings in Europe.

Skogman-Lindqvist C, Lapatto-Reiniluoto O, Sirviö M, Sivén M. Skogman-Lindqvist C, et al. Eur J Pharm Sci. 2023 Dec 1;191:106605. doi: 10.1016/j.ejps.2023.106605. Epub 2023 Oct 10. Eur J Pharm Sci. 2023. PMID: 37821011 Free article. Review.

153

Factorial design of in situ gelling two-compartment systems containing chlorhexidine for the treatment of periodontitis.

Ashfaq R, Sisa B, Kovács A, Berkó S, Szécsényi M, Burián K, Vályi P, Budai-Szűcs M. Ashfaq R, et al. Eur J Pharm Sci. 2023 Dec 1;191:106607. doi: 10.1016/j.ejps.2023.106607. Epub 2023 Oct 10. Eur J Pharm Sci. 2023. PMID: 37821010 Free article.

154

8-octyl berberine combats Staphylococcus aureus by preventing peptidoglycan synthesis.

Li X, Ma Z, Tang Q, Gui Z, Zhang B, Sun G, Li J, Li J, Li M, Li X, Ma H, Ye X. Li X, et al. Eur J Pharm Sci. 2023 Dec 1;191:106602. doi: 10.1016/j.ejps.2023.106602. Epub 2023 Oct 6. Eur J Pharm Sci. 2023. PMID: 37806408 Free article.

155

A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy.

Saharkhiz S, Zarepour A, Nasri N, Cordani M, Zarrabi A. Saharkhiz S, et al. Eur J Pharm Sci. 2023 Dec 1;191:106600. doi: 10.1016/j.ejps.2023.106600. Epub 2023 Oct 5. Eur J Pharm Sci. 2023. PMID: 37802230 Free article.

156

The development of a novel simultaneous in vitro dissolution - in situ perfusion system as a potential tool for studying the absorption of solid oral formulation in rat.

Chen G, Zhu Y, Wang Q, Bai Y, Ma S, Wang J, Zhao M, Zou M, Cheng G. Chen G, et al. Eur J Pharm Sci. 2023 Dec 1;191:106601. doi: 10.1016/j.ejps.2023.106601. Epub 2023 Sep 30. Eur J Pharm Sci. 2023. PMID: 37783379 Free article.

157

A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects.

Yang XM, Yang Y, Yao BF, Ye PP, Xu Y, Peng SP, Yang YM, Shu P, Li PJ, Li S, Hu HL, Li Q, Song LL, Chen KG, Zhou HY, Zhang YH, Zhao FR, Tang BH, Zhang W, Zhang XF, Fu SM, Hao GX, Zheng Y, Shen JS, Xu YC, Jiang XR, Zhang LK, Tang RH, Zhao W. Yang XM, et al. Eur J Pharm Sci. 2023 Dec 1;191:106598. doi: 10.1016/j.ejps.2023.106598. Epub 2023 Sep 30. Eur J Pharm Sci. 2023. PMID: 37783378 Free article. Clinical Trial.

158

Hydrogel containing mPEG-PLGA nanoparticles for the vaginal delivery of saquinavir mesylate against HIV infection.

Tiboni M, Cespi M, Casettari L, Palmieri GF, Perinelli DR, Bonacucina G. Tiboni M, et al. Eur J Pharm Sci. 2023 Dec 1;191:106599. doi: 10.1016/j.ejps.2023.106599. Epub 2023 Sep 27. Eur J Pharm Sci. 2023. PMID: 37774955 Free article.

159

How enzymatic hydrolysis of polysorbate 20 influences colloidal protein stability.

Glücklich N, Carle S, Diederichs T, Buske J, Mäder K, Garidel P. Glücklich N, et al. Eur J Pharm Sci. 2023 Dec 1;191:106597. doi: 10.1016/j.ejps.2023.106597. Epub 2023 Sep 26. Eur J Pharm Sci. 2023. PMID: 37770006 Free article.

160

Optimization of radial extrusion and pellet coating processes using PAT approaches.

Gradišek A, Ratek G, Vrečer F, Korasa K. Gradišek A, et al. Eur J Pharm Sci. 2023 Dec 1;191:106595. doi: 10.1016/j.ejps.2023.106595. Epub 2023 Sep 26. Eur J Pharm Sci. 2023. PMID: 37770005 Free article.

161

On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI).

Graf J, Trautmann-Rodriguez M, Sabnis S, Kloxin AM, Fromen CA. Graf J, et al. Eur J Pharm Sci. 2023 Dec 1;191:106596. doi: 10.1016/j.ejps.2023.106596. Epub 2023 Sep 26. Eur J Pharm Sci. 2023. PMID: 37770004 Free PMC article. Review.

162

Revisiting the pK_a-Flux method for determining intrinsic membrane permeability.

Dahley C, Goss KU, Ebert A. Dahley C, et al. Eur J Pharm Sci. 2023 Dec 1;191:106592. doi: 10.1016/j.ejps.2023.106592. Epub 2023 Sep 24. Eur J Pharm Sci. 2023. PMID: 37751809 Free article.

163

Drug waste of ready-to-administer syringes in the intensive care unit: Aseptically prepared syringes versus prefilled sterilized syringes.

van Gelder TG, Lalmohamed A, Dorst-Mooiman KD, Dekker JC, Schinkel MJ, Sikma MA, Uijtendaal EV, Egberts TCG. van Gelder TG, et al. Eur J Pharm Sci. 2023 Dec 1;191:106590. doi: 10.1016/j.ejps.2023.106590. Epub 2023 Sep 22. Eur J Pharm Sci. 2023. PMID: 37742987 Free article.

164

Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment.

Kurimoto D, Sato A. Kurimoto D, et al. Eur J Pharm Sci. 2023 Dec 1;191:106591. doi: 10.1016/j.ejps.2023.106591. Epub 2023 Sep 23. Eur J Pharm Sci. 2023. PMID: 37742986 Free article.

165

Experience of the adequacy and appropriateness of pharmaceuticals-related environmental information and preferred information channels among Finns.

Alajärvi L, Martikainen J, Timonen J. Alajärvi L, et al. Eur J Pharm Sci. 2023 Dec 1;191:106589. doi: 10.1016/j.ejps.2023.106589. Epub 2023 Sep 21. Eur J Pharm Sci. 2023. PMID: 37739274 Free article.

166

Micro-lightguide spectrophotometry assessment of hepatic and intestinal microcirculation in endotoxemic rats during intravenous treatment with angiotensin II.

Schmidt G, Pitz L, Markmann M, Schneck E, Sander M, Koch C, Edinger F. Schmidt G, et al. Eur J Pharm Sci. 2023 Dec 1;191:106588. doi: 10.1016/j.ejps.2023.106588. Epub 2023 Sep 20. Eur J Pharm Sci. 2023. PMID: 37734468 Free article.

167

Comparison of intravenous ibuprofen pharmacokinetics between Caucasian and Chinese populations using physiologically based pharmacokinetics modeling and simulation.

Jin Y, Zhang M, Di X, Qi X, Zheng L, Wang Z. Jin Y, et al. Eur J Pharm Sci. 2023 Dec 1;191:106587. doi: 10.1016/j.ejps.2023.106587. Epub 2023 Sep 20. Eur J Pharm Sci. 2023. PMID: 37734467 Free article.

168

Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells.

Fernandes Q, Therachiyil L, Khan AQ, Bedhiafi T, Korashy HM, Bhat AA, Uddin S. Fernandes Q, et al. Eur J Pharm Sci. 2023 Dec 1;191:106586. doi: 10.1016/j.ejps.2023.106586. Epub 2023 Sep 19. Eur J Pharm Sci. 2023. PMID: 37729956 Free article. Review.

169

Organic-inorganic hybrid nanoflowers as a new biomimetic platform for ROS-induced apoptosis by photodynamic therapy.

Borghei YS, Hamidieh AA, Lu Y, Hosseinkhani S. Borghei YS, et al. Eur J Pharm Sci. 2023 Dec 1;191:106569. doi: 10.1016/j.ejps.2023.106569. Epub 2023 Aug 24. Eur J Pharm Sci. 2023. PMID: 37633340 Free article.

170

Advancing algorithmic drug product development: Recommendations for machine learning approaches in drug formulation.

Murray JD, Lange JJ, Bennett-Lenane H, Holm R, Kuentz M, O'Dwyer PJ, Griffin BT. Murray JD, et al. Eur J Pharm Sci. 2023 Dec 1;191:106562. doi: 10.1016/j.ejps.2023.106562. Epub 2023 Aug 9. Eur J Pharm Sci. 2023. PMID: 37562550 Free article. Review.

171

TAT decorated siRNA polyplexes for inhalation delivery in anti-asthma therapy.

Drago SE, Cabibbo M, Craparo EF, Cavallaro G. Drago SE, et al. Eur J Pharm Sci. 2023 Nov 1;190:106580. doi: 10.1016/j.ejps.2023.106580. Epub 2023 Sep 16. Eur J Pharm Sci. 2023. PMID: 37717668 Free article.

172

Recent engineering advances of EVs for compounds, nucleic acids, and TCM delivery.

Di Y, Wang W, Wang Y, Wang J. Di Y, et al. Eur J Pharm Sci. 2023 Nov 1;190:106584. doi: 10.1016/j.ejps.2023.106584. Epub 2023 Sep 15. Eur J Pharm Sci. 2023. PMID: 37717667 Free article. Review.

173

Attenuation of celecoxib cardiac toxicity using Poly(δ-decalactone) based nanoemulsion via oral route.

Maru S, Verma J, Wilen CE, Rosenholm JM, Bansal KK. Maru S, et al. Eur J Pharm Sci. 2023 Nov 1;190:106585. doi: 10.1016/j.ejps.2023.106585. Epub 2023 Sep 16. Eur J Pharm Sci. 2023. PMID: 37717666 Free article.

174

Possibilities and advantages of additive manufacturing in dry powder formulations for inhalation.

Wostry M, Scherließ R. Wostry M, et al. Eur J Pharm Sci. 2023 Nov 1;190:106583. doi: 10.1016/j.ejps.2023.106583. Epub 2023 Sep 12. Eur J Pharm Sci. 2023. PMID: 37703932 Free article.

175

Inhibiting autophagy to boost antitumor immunity with tetramethylpyrazine-loaded and PD-L1-targeting liposomal nanoparticles.

Zhou F, Li X, Jia K, Li F, Xue X, Liu J, Qu J, Liu R. Zhou F, et al. Eur J Pharm Sci. 2023 Nov 1;190:106581. doi: 10.1016/j.ejps.2023.106581. Epub 2023 Sep 9. Eur J Pharm Sci. 2023. PMID: 37696460 Free article.

176

Redefine the role of d-α-Tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein, multidrug resistance protein 1, and breast cancer resistance protein mediated cancer multidrug resistance.

Chen JY, Sung CJ, Chen SC, Hsiang YP, Hsu YC, Teng YN. Chen JY, et al. Eur J Pharm Sci. 2023 Nov 1;190:106579. doi: 10.1016/j.ejps.2023.106579. Epub 2023 Sep 9. Eur J Pharm Sci. 2023. PMID: 37689120 Free article.

177

Physiologically based pharmacokinetic modeling to characterize enterohepatic recirculation and predict food effect on the pharmacokinetics of hyzetimibe.

Chen W, Ruan Z, Lou H, Yang D, Chen J, Shao R, Jiang B. Chen W, et al. Eur J Pharm Sci. 2023 Nov 1;190:106576. doi: 10.1016/j.ejps.2023.106576. Epub 2023 Sep 6. Eur J Pharm Sci. 2023. PMID: 37678518 Free article.

178

Corrigendum to "Personalizing oral delivery of nanoformed piroxicam by semi-solid extrusion 3D printing" European Journal of Pharmaceutical Sciences 188 (2023) 106497.

Mathiyalagan R, Sjöholm E, Manandhar S, Lakio S, Rosenholm JM, Kaasalainen M, Wang X, Sandler N. Mathiyalagan R, et al. Eur J Pharm Sci. 2023 Nov 1;190:106575. doi: 10.1016/j.ejps.2023.106575. Epub 2023 Sep 4. Eur J Pharm Sci. 2023. PMID: 37673750 Free article. No abstract available.

179

Quantitative risk-benefit profiles of oral contraceptives, insulin sensitizers and antiandrogens for women with polycystic ovary syndrome: A model-based meta-analysis.

Tang Z, Guan J, Mao JH, Han L, Zhang JJ, Chen R, Jiao Z. Tang Z, et al. Eur J Pharm Sci. 2023 Nov 1;190:106577. doi: 10.1016/j.ejps.2023.106577. Epub 2023 Sep 2. Eur J Pharm Sci. 2023. PMID: 37666459 Free article.

180

Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects.

Zhou S, Xie L, Zhou C, Zhao Y, Wang L, Ding S, Chen J, Zhu B, Su M, Shao F. Zhou S, et al. Eur J Pharm Sci. 2023 Nov 1;190:106578. doi: 10.1016/j.ejps.2023.106578. Epub 2023 Sep 4. Eur J Pharm Sci. 2023. PMID: 37666458 Free article.

181

Biomimetic lipid nanoparticles for homologous-targeting and enhanced photodynamic therapy against glioma.

Zhang F, Wen C, Peng Y, Hu Z, Zheng S, Chen W, Wen L. Zhang F, et al. Eur J Pharm Sci. 2023 Nov 1;190:106574. doi: 10.1016/j.ejps.2023.106574. Epub 2023 Sep 1. Eur J Pharm Sci. 2023. PMID: 37659459 Free article.

182

Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours.

Petruk N, Sousa S, Croset M, Polari L, Zlatev H, Selander K, Mönkkönen J, Clézardin P, Määttä J. Petruk N, et al. Eur J Pharm Sci. 2023 Nov 1;190:106571. doi: 10.1016/j.ejps.2023.106571. Epub 2023 Aug 29. Eur J Pharm Sci. 2023. PMID: 37652236 Free article.

183

Targeting Lewis X oligosaccharide-modified liposomes encapsulated with house dust mite allergen Der f 2 to dendritic cells inhibits Th2 immune response.

Peng X, Ge Y, Li W, Lin X, Song H, Lin L, Zhao J, Gao Y, Wang J, Li J, Huang Y, Li Y, Li L. Peng X, et al. Eur J Pharm Sci. 2023 Nov 1;190:106570. doi: 10.1016/j.ejps.2023.106570. Epub 2023 Aug 26. Eur J Pharm Sci. 2023. PMID: 37634600 Free article.

184

The development and characterization of in vivo-like three-dimensional models of bronchial epithelial cell lines.

Van den Bossche S, Ostyn L, Vandendriessche V, Rigauts C, De Keersmaecker H, Nickerson CA, Crabbé A. Van den Bossche S, et al. Eur J Pharm Sci. 2023 Nov 1;190:106567. doi: 10.1016/j.ejps.2023.106567. Epub 2023 Aug 24. Eur J Pharm Sci. 2023. PMID: 37633341 Free article.

185

Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation.

Plavec TV, Klemenčič K, Kuchař M, Malý P, Berlec A. Plavec TV, et al. Eur J Pharm Sci. 2023 Nov 1;190:106568. doi: 10.1016/j.ejps.2023.106568. Epub 2023 Aug 22. Eur J Pharm Sci. 2023. PMID: 37619953 Free article.

186

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference.

Mehta M, Schug B, Blume HH, Beuerle G, Jiang W, Koenig J, Paixao P, Tampal N, Tsang YC, Walstab J, Wedemeyer R, Welink J. Mehta M, et al. Eur J Pharm Sci. 2023 Nov 1;190:106566. doi: 10.1016/j.ejps.2023.106566. Epub 2023 Aug 15. Eur J Pharm Sci. 2023. PMID: 37591469 Free article. Review.

187

Pharmacokinetics, safety, and efficacy of GM1 ganglioside in healthy subjects and patients with multiple myeloma: Two dose-escalation studies.

Kuang Y, Ding Q, Huang J, Yang S, Yao A, Yang X, Xiao M, Pei Q, Yang G. Kuang Y, et al. Eur J Pharm Sci. 2023 Nov 1;190:106565. doi: 10.1016/j.ejps.2023.106565. Epub 2023 Aug 14. Eur J Pharm Sci. 2023. PMID: 37586437 Free article.

188

Exploring novel and fast stability or sameness evaluation tool for different categories of injectable formulations.

Patel V, Aggarwal P, Sarvaiya J, Maity P, Ravichandiran V, Kaity S. Patel V, et al. Eur J Pharm Sci. 2023 Nov 1;190:106551. doi: 10.1016/j.ejps.2023.106551. Epub 2023 Aug 9. Eur J Pharm Sci. 2023. PMID: 37562551 Free article.

189

Mimicking 3D breast tumor-stromal interactions to screen novel cancer therapeutics.

Domingues M, Leite Pereira C, Sarmento B, Castro F. Domingues M, et al. Eur J Pharm Sci. 2023 Nov 1;190:106560. doi: 10.1016/j.ejps.2023.106560. Epub 2023 Aug 7. Eur J Pharm Sci. 2023. PMID: 37557927 Free article.

190

Assessing extent of brain penetration in vivo (K_p,uu,brain) in Göttingen minipig using a diverse set of reference drugs.

Langthaler K, Jones CR, Brodin B, Bundgaard C. Langthaler K, et al. Eur J Pharm Sci. 2023 Nov 1;190:106554. doi: 10.1016/j.ejps.2023.106554. Epub 2023 Aug 3. Eur J Pharm Sci. 2023. PMID: 37543065 Free article.

191

Low-dose apatinib in subjects with renal impairment: A pharmacokinetics study.

Liu J, Li W, Zhang K, Huang J, Zhang X, Lei Y, Liu J, Sun J, Yang G, Zhang H. Liu J, et al. Eur J Pharm Sci. 2023 Nov 1;190:106536. doi: 10.1016/j.ejps.2023.106536. Epub 2023 Jul 23. Eur J Pharm Sci. 2023. PMID: 37490973 Free article.

192

Solidification and oral delivery of biologics to the colon- A review.

Kopp KT, Saerens L, Voorspoels J, Van den Mooter G. Kopp KT, et al. Eur J Pharm Sci. 2023 Nov 1;190:106523. doi: 10.1016/j.ejps.2023.106523. Epub 2023 Jul 8. Eur J Pharm Sci. 2023. PMID: 37429482 Free article. Review.

193

Drug-drug interactions and dose management of BTK inhibitors when initiating nirmatrelvir/ritonavir (paxlovid) based on physiologically-based pharmacokinetic models.

Li C, Chen L, Li L, Chen W. Li C, et al. Eur J Pharm Sci. 2023 Oct 1;189:106564. doi: 10.1016/j.ejps.2023.106564. Epub 2023 Aug 14. Eur J Pharm Sci. 2023. PMID: 37586436 Free article.

194

In-line particle size measurement during granule fluidization using convolutional neural network-aided process imaging.

Péterfi O, Madarász L, Ficzere M, Lestyán-Goda K, Záhonyi P, Erdei G, Sipos E, Nagy ZK, Galata DL. Péterfi O, et al. Eur J Pharm Sci. 2023 Oct 1;189:106563. doi: 10.1016/j.ejps.2023.106563. Epub 2023 Aug 13. Eur J Pharm Sci. 2023. PMID: 37582409 Free article.

195

Viral protein-based nanoparticles (part 2): Pharmaceutical applications.

Mellid-Carballal R, Gutierrez-Gutierrez S, Rivas C, Garcia-Fuentes M. Mellid-Carballal R, et al. Eur J Pharm Sci. 2023 Oct 1;189:106558. doi: 10.1016/j.ejps.2023.106558. Epub 2023 Aug 9. Eur J Pharm Sci. 2023. PMID: 37567394 Free article. Review.

196

Enhanced cytotoxicity to lung cancer cells by mitochondrial delivery of camptothecin.

Xie J, Wang H, Huang Q, Lin J, Wen H, Miao Y, Lv L, Ruan D, Yu X, Qin L, Zhou Y. Xie J, et al. Eur J Pharm Sci. 2023 Oct 1;189:106561. doi: 10.1016/j.ejps.2023.106561. Epub 2023 Aug 8. Eur J Pharm Sci. 2023. PMID: 37562549 Free article.

197

Interpreting permeability as a function of free drug fraction: The case studies of cyclodextrins and liposomes.

Tzanova MM, Nguyen L, Moretti F, Grassi M, Magnano GC, Voinovich D, Stein PC, Hiorth M, di Cagno MP. Tzanova MM, et al. Eur J Pharm Sci. 2023 Oct 1;189:106559. doi: 10.1016/j.ejps.2023.106559. Epub 2023 Aug 5. Eur J Pharm Sci. 2023. PMID: 37544334 Free article.

198

Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability study.

Mitrović JR, Bjelošević Žiberna M, Vukadinović A, Knutson DE, Sharmin D, Kremenović A, Ahlin Grabnar P, Planinšek O, Lunter D, Cook JM, Savić MM, Savić SD. Mitrović JR, et al. Eur J Pharm Sci. 2023 Oct 1;189:106557. doi: 10.1016/j.ejps.2023.106557. Epub 2023 Aug 6. Eur J Pharm Sci. 2023. PMID: 37544333 Free article.

199

A novel pH-responsive hydrogel system based on Prunus armeniaca gum and acrylic acid: Preparation and evaluation as a potential candidate for controlled drug delivery.

Noureen S, Noreen S, Ghumman SA, Abdelrahman EA, Batool F, Aslam A, Mehdi M, Shirinfar B, Ahmed N. Noureen S, et al. Eur J Pharm Sci. 2023 Oct 1;189:106555. doi: 10.1016/j.ejps.2023.106555. Epub 2023 Aug 4. Eur J Pharm Sci. 2023. PMID: 37543064 Free article.

200

Lipid based formulations as supersaturating oral delivery systems: From current to future industrial applications.

Holm R, Kuentz M, Ilie-Spiridon AR, Griffin BT. Holm R, et al. Eur J Pharm Sci. 2023 Oct 1;189:106556. doi: 10.1016/j.ejps.2023.106556. Epub 2023 Aug 4. Eur J Pharm Sci. 2023. PMID: 37543063 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

5,987 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

5,987 results

Results by year